Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines > GIAS | 2017 | Publicaciones Autor: Arellano AL y otros Revista: CNS Neurol Disord Drug Targets Fuente: Pubmed/28412920 Volver a Publicaciones ← Long-Term Mortality of Patients with an Alcohol-Related Wernicke-Korsakoff Syndrome Patients with alcohol use disorder: initial results from a prospective multicenter registry in the Spanish Network on Addiction Disorders. CohRTA Study →
